Deep transfer learning approaches for Monkeypox disease diagnosis.

Monkeypox has become a significant global challenge as the number of cases increases daily. Those infected with the disease often display various skin symptoms and can spread the infection through contamination. Recently, Machine Learning (ML) has shown potential in image-based diagnoses, such as detecting cancer, identifying tumor cells, and identifying coronavirus disease (COVID)-19 patients. Thus, ML could potentially be used to diagnose Monkeypox as well. In this study, we developed a Monkeypox diagnosis model using Generalization and Regularization-based Transfer Learning approaches (GRA-TLA) for binary and multiclass classification. We tested our proposed approach on ten different convolutional Neural Network (CNN) models in three separate studies. The preliminary computational results showed that our proposed approach, combined with Extreme Inception (Xception), was able to distinguish between individuals with and without Monkeypox with an accuracy ranging from 77% to 88% in Studies One and Two, while Residual Network (ResNet)-101 had the best performance for multiclass classification in Study Three, with an accuracy ranging from 84% to 99%. In addition, we found that our proposed approach was computationally efficient compared to existing TL approaches in terms of the number of parameters (NP) and Floating-Point Operations per Second (FLOPs) required. We also used Local Interpretable Model-Agnostic Explanations (LIME) to explain our model's predictions and feature extractions, providing a deeper understanding of the specific features that may indicate the onset of Monkeypox.

Machine-Learning-Based Disease Diagnosis: A Comprehensive Review.

Globally, there is a substantial unmet need to diagnose various diseases effectively. The complexity of the different disease mechanisms and underlying symptoms of the patient population presents massive challenges in developing the early diagnosis tool and effective treatment. Machine learning (ML), an area of artificial intelligence (AI), enables researchers, physicians, and patients to solve some of these issues. Based on relevant research, this review explains how machine learning (ML) is being used to help in the early identification of numerous diseases. Initially, a bibliometric analysis of the publication is carried out using data from the Scopus and Web of Science (WOS) databases. The bibliometric study of 1216 publications was undertaken to determine the most prolific authors, nations, organizations, and most cited articles. The review then summarizes the most recent trends and approaches in machine-learning-based disease diagnosis (MLBDD), considering the following factors: algorithm, disease types, data type, application, and evaluation metrics. Finally, in this paper, we highlight key results and provides insight into future trends and opportunities in the MLBDD area.

Detecting SARS-CoV-2 From Chest X-Ray Using Artificial Intelligence.

Chest radiographs (X-rays) combined with Deep Convolutional Neural Network (CNN) methods have been demonstrated to detect and diagnose the onset of COVID-19, the disease caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). However, questions remain regarding the accuracy of those methods as they are often challenged by limited datasets, performance legitimacy on imbalanced data, and have their results typically reported without proper confidence intervals. Considering the opportunity to address these issues, in this study, we propose and test six modified deep learning models, including VGG16, InceptionResNetV2, ResNet50, MobileNetV2, ResNet101, and VGG19 to detect SARS-CoV-2 infection from chest X-ray images. Results are evaluated in terms of accuracy, precision, recall, and f- score using a small and balanced dataset (Study One), and a larger and imbalanced dataset (Study Two). With 95% confidence interval, VGG16 and MobileNetV2 show that, on both datasets, the model could identify patients with COVID-19 symptoms with an accuracy of up to 100%. We also present a pilot test of VGG16 models on a multi-class dataset, showing promising results by achieving 91% accuracy in detecting COVID-19, normal, and Pneumonia patients. Furthermore, we demonstrated that poorly performing models in Study One (ResNet50 and ResNet101) had their accuracy rise from 70% to 93% once trained with the comparatively larger dataset of Study Two. Still, models like InceptionResNetV2 and VGG19's demonstrated an accuracy of 97% on both datasets, which posits the effectiveness of our proposed methods, ultimately presenting a reasonable and accessible alternative to identify patients with COVID-19.